法尼醇X受体(farnesol X receptor,FXR),又称为胆汁酸核受体,是配体依赖性的核转录因子,可分布于体内肝脏、肠道等多个组织器官;胆汁酸是其内源性天然配体。近年有研究表明,肠道FXR对于糖脂代谢调节具有不可或缺的作用,肠道特异性FXR激...法尼醇X受体(farnesol X receptor,FXR),又称为胆汁酸核受体,是配体依赖性的核转录因子,可分布于体内肝脏、肠道等多个组织器官;胆汁酸是其内源性天然配体。近年有研究表明,肠道FXR对于糖脂代谢调节具有不可或缺的作用,肠道特异性FXR激动剂或抑制剂均可参与体内糖脂代谢调节。该文对近年来报道的肠道FXR在糖脂代谢中的作用进行系统的综述。展开更多
As obesity continues to escalate worldwide,nonalcoholic fatty liver disease(NAFLD)has emerged as the most prevalent form of liver disease,with a reported global prevalence of 30.1%(1).The prevalence of NAFLD,which was...As obesity continues to escalate worldwide,nonalcoholic fatty liver disease(NAFLD)has emerged as the most prevalent form of liver disease,with a reported global prevalence of 30.1%(1).The prevalence of NAFLD,which was around 25%in the 1990s,has been increasing year by year in recent years and has exceeded 35%in the past few years(1).The spectrum of disease includes nonalcoholic fatty liver(NAFL),characterized by macrovesicular hepatic steatosis that may be accompanied by mild inflammation,and nonalcoholic steatohepatitis(NASH),which is additionally characterized by the presence of inflammation and cellular injury(2).展开更多
文摘法尼醇X受体(farnesol X receptor,FXR),又称为胆汁酸核受体,是配体依赖性的核转录因子,可分布于体内肝脏、肠道等多个组织器官;胆汁酸是其内源性天然配体。近年有研究表明,肠道FXR对于糖脂代谢调节具有不可或缺的作用,肠道特异性FXR激动剂或抑制剂均可参与体内糖脂代谢调节。该文对近年来报道的肠道FXR在糖脂代谢中的作用进行系统的综述。
文摘As obesity continues to escalate worldwide,nonalcoholic fatty liver disease(NAFLD)has emerged as the most prevalent form of liver disease,with a reported global prevalence of 30.1%(1).The prevalence of NAFLD,which was around 25%in the 1990s,has been increasing year by year in recent years and has exceeded 35%in the past few years(1).The spectrum of disease includes nonalcoholic fatty liver(NAFL),characterized by macrovesicular hepatic steatosis that may be accompanied by mild inflammation,and nonalcoholic steatohepatitis(NASH),which is additionally characterized by the presence of inflammation and cellular injury(2).
